nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—Pseudoephedrine—NFATC1—rheumatoid arthritis	0.0253	0.663	CrCbGaD
Methamphetamine—Digestion impaired—Leflunomide—rheumatoid arthritis	0.00979	0.0457	CcSEcCtD
Methamphetamine—Pseudoephedrine—IL2—rheumatoid arthritis	0.00881	0.231	CrCbGaD
Methamphetamine—Digestion impaired—Cyclosporine—rheumatoid arthritis	0.00756	0.0353	CcSEcCtD
Methamphetamine—Constipation—Ergocalciferol—rheumatoid arthritis	0.0054	0.0252	CcSEcCtD
Methamphetamine—Agitation—Penicillamine—rheumatoid arthritis	0.00535	0.025	CcSEcCtD
Methamphetamine—Dyspepsia—Auranofin—rheumatoid arthritis	0.00453	0.0211	CcSEcCtD
Methamphetamine—Constipation—Auranofin—rheumatoid arthritis	0.0044	0.0205	CcSEcCtD
Methamphetamine—Urticaria—Auranofin—rheumatoid arthritis	0.00409	0.0191	CcSEcCtD
Methamphetamine—Euphoric mood—Prednisolone—rheumatoid arthritis	0.00395	0.0184	CcSEcCtD
Methamphetamine—Euphoric mood—Hydrocortisone—rheumatoid arthritis	0.00386	0.018	CcSEcCtD
Methamphetamine—Urticaria—Penicillamine—rheumatoid arthritis	0.00377	0.0176	CcSEcCtD
Methamphetamine—Euphoric mood—Triamcinolone—rheumatoid arthritis	0.00363	0.0169	CcSEcCtD
Methamphetamine—Euphoric mood—Methylprednisolone—rheumatoid arthritis	0.00363	0.0169	CcSEcCtD
Methamphetamine—Diarrhoea—Auranofin—rheumatoid arthritis	0.00352	0.0164	CcSEcCtD
Methamphetamine—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.0035	0.0163	CcSEcCtD
Methamphetamine—Euphoric mood—Betamethasone—rheumatoid arthritis	0.0033	0.0154	CcSEcCtD
Methamphetamine—Euphoric mood—Dexamethasone—rheumatoid arthritis	0.0033	0.0154	CcSEcCtD
Methamphetamine—Diarrhoea—Penicillamine—rheumatoid arthritis	0.00325	0.0152	CcSEcCtD
Methamphetamine—Psychotic disorder—Hydrocortisone—rheumatoid arthritis	0.00318	0.0149	CcSEcCtD
Methamphetamine—Psychotic disorder—Methylprednisolone—rheumatoid arthritis	0.00299	0.014	CcSEcCtD
Methamphetamine—Pseudoephedrine—TNF—rheumatoid arthritis	0.00297	0.0779	CrCbGaD
Methamphetamine—Euphoric mood—Prednisone—rheumatoid arthritis	0.00287	0.0134	CcSEcCtD
Methamphetamine—Psychotic disorder—Dexamethasone—rheumatoid arthritis	0.00272	0.0127	CcSEcCtD
Methamphetamine—Psychotic disorder—Betamethasone—rheumatoid arthritis	0.00272	0.0127	CcSEcCtD
Methamphetamine—Palpitations—Leflunomide—rheumatoid arthritis	0.00253	0.0118	CcSEcCtD
Methamphetamine—Psychotic disorder—Prednisone—rheumatoid arthritis	0.00237	0.011	CcSEcCtD
Methamphetamine—Tachycardia—Leflunomide—rheumatoid arthritis	0.00228	0.0106	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.00214	0.00996	CcSEcCtD
Methamphetamine—Insomnia—Leflunomide—rheumatoid arthritis	0.00211	0.00985	CcSEcCtD
Methamphetamine—Tremor—Cyclosporine—rheumatoid arthritis	0.00207	0.00965	CcSEcCtD
Methamphetamine—Dyspepsia—Leflunomide—rheumatoid arthritis	0.00206	0.00959	CcSEcCtD
Methamphetamine—Agitation—Cyclosporine—rheumatoid arthritis	0.00203	0.00947	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.00202	0.00941	CcSEcCtD
Methamphetamine—Constipation—Leflunomide—rheumatoid arthritis	0.002	0.00932	CcSEcCtD
Methamphetamine—Erectile dysfunction—Prednisone—rheumatoid arthritis	0.00193	0.00901	CcSEcCtD
Methamphetamine—Urticaria—Leflunomide—rheumatoid arthritis	0.00186	0.00866	CcSEcCtD
Methamphetamine—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.00182	0.0085	CcSEcCtD
Methamphetamine—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.00172	0.00803	CcSEcCtD
Methamphetamine—Diarrhoea—Azathioprine—rheumatoid arthritis	0.00169	0.00789	CcSEcCtD
Methamphetamine—Dizziness—Azathioprine—rheumatoid arthritis	0.00164	0.00763	CcSEcCtD
Methamphetamine—Insomnia—Cyclosporine—rheumatoid arthritis	0.00163	0.00761	CcSEcCtD
Methamphetamine—Erectile dysfunction—Methotrexate—rheumatoid arthritis	0.00161	0.00753	CcSEcCtD
Methamphetamine—Tachycardia—Prednisolone—rheumatoid arthritis	0.0016	0.00747	CcSEcCtD
Methamphetamine—Diarrhoea—Leflunomide—rheumatoid arthritis	0.0016	0.00746	CcSEcCtD
Methamphetamine—Dyspepsia—Cyclosporine—rheumatoid arthritis	0.00159	0.0074	CcSEcCtD
Methamphetamine—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.00156	0.00729	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.00156	0.00726	CcSEcCtD
Methamphetamine—Headache—Azathioprine—rheumatoid arthritis	0.00155	0.00723	CcSEcCtD
Methamphetamine—Dizziness—Leflunomide—rheumatoid arthritis	0.00154	0.00721	CcSEcCtD
Methamphetamine—Constipation—Cyclosporine—rheumatoid arthritis	0.00154	0.00719	CcSEcCtD
Methamphetamine—Insomnia—Prednisolone—rheumatoid arthritis	0.00148	0.00692	CcSEcCtD
Methamphetamine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.00147	0.00687	CcSEcCtD
Methamphetamine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.00147	0.00685	CcSEcCtD
Methamphetamine—Headache—Leflunomide—rheumatoid arthritis	0.00146	0.00683	CcSEcCtD
Methamphetamine—Insomnia—Hydrocortisone—rheumatoid arthritis	0.00145	0.00676	CcSEcCtD
Methamphetamine—Urticaria—Cyclosporine—rheumatoid arthritis	0.00143	0.00668	CcSEcCtD
Methamphetamine—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.00141	0.00658	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.00138	0.00645	CcSEcCtD
Methamphetamine—Insomnia—Triamcinolone—rheumatoid arthritis	0.00136	0.00636	CcSEcCtD
Methamphetamine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.00136	0.00635	CcSEcCtD
Methamphetamine—Agitation—Prednisone—rheumatoid arthritis	0.00134	0.00626	CcSEcCtD
Methamphetamine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.00134	0.00623	CcSEcCtD
Methamphetamine—Tachycardia—Betamethasone—rheumatoid arthritis	0.00134	0.00623	CcSEcCtD
Methamphetamine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00133	0.0062	CcSEcCtD
Methamphetamine—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00133	0.00619	CcSEcCtD
Methamphetamine—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.00133	0.00618	CcSEcCtD
Methamphetamine—Urticaria—Prednisolone—rheumatoid arthritis	0.0013	0.00608	CcSEcCtD
Methamphetamine—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00127	0.00594	CcSEcCtD
Methamphetamine—Insomnia—Dexamethasone—rheumatoid arthritis	0.00124	0.00577	CcSEcCtD
Methamphetamine—Insomnia—Betamethasone—rheumatoid arthritis	0.00124	0.00577	CcSEcCtD
Methamphetamine—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00123	0.00575	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00121	0.00564	CcSEcCtD
Methamphetamine—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.0012	0.00562	CcSEcCtD
Methamphetamine—Dyspepsia—Betamethasone—rheumatoid arthritis	0.0012	0.00562	CcSEcCtD
Methamphetamine—Urticaria—Triamcinolone—rheumatoid arthritis	0.0012	0.00559	CcSEcCtD
Methamphetamine—Urticaria—Methylprednisolone—rheumatoid arthritis	0.0012	0.00558	CcSEcCtD
Methamphetamine—Dizziness—Cyclosporine—rheumatoid arthritis	0.00119	0.00556	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00118	0.00551	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00118	0.00551	CcSEcCtD
Methamphetamine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.00118	0.00551	CcSEcCtD
Methamphetamine—Tachycardia—Prednisone—rheumatoid arthritis	0.00116	0.00543	CcSEcCtD
Methamphetamine—Headache—Cyclosporine—rheumatoid arthritis	0.00113	0.00527	CcSEcCtD
Methamphetamine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.00111	0.00518	CcSEcCtD
Methamphetamine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.00111	0.00517	CcSEcCtD
Methamphetamine—Nateglinide—ALB—rheumatoid arthritis	0.0011	0.0288	CrCbGaD
Methamphetamine—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.0011	0.00511	CcSEcCtD
Methamphetamine—Urticaria—Betamethasone—rheumatoid arthritis	0.00109	0.00507	CcSEcCtD
Methamphetamine—Urticaria—Dexamethasone—rheumatoid arthritis	0.00109	0.00507	CcSEcCtD
Methamphetamine—Dizziness—Prednisolone—rheumatoid arthritis	0.00108	0.00506	CcSEcCtD
Methamphetamine—Insomnia—Prednisone—rheumatoid arthritis	0.00108	0.00503	CcSEcCtD
Methamphetamine—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00106	0.00494	CcSEcCtD
Methamphetamine—Dyspepsia—Prednisone—rheumatoid arthritis	0.00105	0.00489	CcSEcCtD
Methamphetamine—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.00103	0.0048	CcSEcCtD
Methamphetamine—Headache—Prednisolone—rheumatoid arthritis	0.00103	0.00479	CcSEcCtD
Methamphetamine—Constipation—Prednisone—rheumatoid arthritis	0.00102	0.00475	CcSEcCtD
Methamphetamine—Headache—Hydrocortisone—rheumatoid arthritis	0.001	0.00468	CcSEcCtD
Methamphetamine—Dizziness—Triamcinolone—rheumatoid arthritis	0.000998	0.00465	CcSEcCtD
Methamphetamine—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000995	0.00464	CcSEcCtD
Methamphetamine—Urticaria—Prednisone—rheumatoid arthritis	0.000947	0.00442	CcSEcCtD
Methamphetamine—Headache—Triamcinolone—rheumatoid arthritis	0.000945	0.00441	CcSEcCtD
Methamphetamine—Headache—Methylprednisolone—rheumatoid arthritis	0.000943	0.0044	CcSEcCtD
Methamphetamine—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000937	0.00437	CcSEcCtD
Methamphetamine—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000937	0.00437	CcSEcCtD
Methamphetamine—Dizziness—Dexamethasone—rheumatoid arthritis	0.000905	0.00422	CcSEcCtD
Methamphetamine—Dizziness—Betamethasone—rheumatoid arthritis	0.000905	0.00422	CcSEcCtD
Methamphetamine—Insomnia—Methotrexate—rheumatoid arthritis	0.000901	0.0042	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000878	0.0041	CcSEcCtD
Methamphetamine—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000877	0.00409	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.00086	0.00401	CcSEcCtD
Methamphetamine—Headache—Betamethasone—rheumatoid arthritis	0.000858	0.004	CcSEcCtD
Methamphetamine—Headache—Dexamethasone—rheumatoid arthritis	0.000858	0.004	CcSEcCtD
Methamphetamine—Diarrhoea—Prednisone—rheumatoid arthritis	0.000816	0.0038	CcSEcCtD
Methamphetamine—Urticaria—Methotrexate—rheumatoid arthritis	0.000791	0.00369	CcSEcCtD
Methamphetamine—Dizziness—Prednisone—rheumatoid arthritis	0.000788	0.00368	CcSEcCtD
Methamphetamine—Headache—Prednisone—rheumatoid arthritis	0.000747	0.00348	CcSEcCtD
Methamphetamine—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000734	0.00342	CcSEcCtD
Methamphetamine—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000682	0.00318	CcSEcCtD
Methamphetamine—Dizziness—Methotrexate—rheumatoid arthritis	0.000659	0.00307	CcSEcCtD
Methamphetamine—Headache—Methotrexate—rheumatoid arthritis	0.000624	0.00291	CcSEcCtD
Methamphetamine—ADRA2A—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000145	0.000195	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	0.000145	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000145	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000144	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000143	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000143	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL3—rheumatoid arthritis	0.000143	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000142	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NCF2—rheumatoid arthritis	0.000142	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IL2—rheumatoid arthritis	0.000142	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—C3—rheumatoid arthritis	0.000142	0.000189	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000141	0.000188	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—POMC—rheumatoid arthritis	0.000141	0.000188	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SAA1—rheumatoid arthritis	0.00014	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000139	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000138	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000138	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000138	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—C3—rheumatoid arthritis	0.000138	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GZMB—rheumatoid arthritis	0.000137	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000137	0.000183	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TLE3—rheumatoid arthritis	0.000137	0.000183	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NCF1—rheumatoid arthritis	0.000137	0.000183	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TGFB1—rheumatoid arthritis	0.000136	0.000182	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000136	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000133	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL3—rheumatoid arthritis	0.000133	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—ALB—rheumatoid arthritis	0.000133	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IL2—rheumatoid arthritis	0.000132	0.000177	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CAT—rheumatoid arthritis	0.000132	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000132	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD28—rheumatoid arthritis	0.000131	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000131	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SAA1—rheumatoid arthritis	0.00013	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2RB—rheumatoid arthritis	0.00013	0.000175	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.00013	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000129	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—C3—rheumatoid arthritis	0.000129	0.000172	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ALB—rheumatoid arthritis	0.000128	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NCF1—rheumatoid arthritis	0.000128	0.000171	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MED1—rheumatoid arthritis	0.000127	0.000171	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NOS3—rheumatoid arthritis	0.000127	0.00017	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—C5—rheumatoid arthritis	0.000126	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000126	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000126	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000124	0.000166	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000124	0.000166	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD28—rheumatoid arthritis	0.000123	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ENO1—rheumatoid arthritis	0.000123	0.000164	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—NOS3—rheumatoid arthritis	0.000123	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000121	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000121	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000121	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—VEGFA—rheumatoid arthritis	0.000121	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.00012	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.00012	0.000161	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—POMC—rheumatoid arthritis	0.000119	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000119	0.000159	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	0.000118	0.000159	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	0.000118	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR6—rheumatoid arthritis	0.000118	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000118	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000117	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000116	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000116	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NCF2—rheumatoid arthritis	0.000115	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—C3—rheumatoid arthritis	0.000115	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000113	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000113	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000113	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000113	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SYK—rheumatoid arthritis	0.000113	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—VEGFA—rheumatoid arthritis	0.000113	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000112	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000112	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000112	0.00015	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—rheumatoid arthritis	0.000112	0.00015	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—rheumatoid arthritis	0.000112	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000112	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GZMB—rheumatoid arthritis	0.000112	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000111	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—rheumatoid arthritis	0.000111	0.000148	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—MTHFR—rheumatoid arthritis	0.00011	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—POMC—rheumatoid arthritis	0.00011	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAT—rheumatoid arthritis	0.000109	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT1—rheumatoid arthritis	0.000109	0.000146	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—rheumatoid arthritis	0.000109	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL3—rheumatoid arthritis	0.000108	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000108	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000108	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2—rheumatoid arthritis	0.000108	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000107	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000107	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000107	0.000143	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—BGN—rheumatoid arthritis	0.000107	0.000143	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SAA1—rheumatoid arthritis	0.000106	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000106	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SYK—rheumatoid arthritis	0.000105	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000105	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—C3—rheumatoid arthritis	0.000104	0.00014	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—NOS3—rheumatoid arthritis	0.000104	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NCF1—rheumatoid arthritis	0.000104	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000103	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—rheumatoid arthritis	0.000103	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—POMC—rheumatoid arthritis	0.000103	0.000138	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—rheumatoid arthritis	0.000103	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT1—rheumatoid arthritis	0.000102	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000101	0.000135	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6R—rheumatoid arthritis	0.0001	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL10—rheumatoid arthritis	0.0001	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD28—rheumatoid arthritis	9.98e-05	0.000133	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	9.82e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP3—rheumatoid arthritis	9.79e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—TYK2—rheumatoid arthritis	9.78e-05	0.000131	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—rheumatoid arthritis	9.5e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTK2—rheumatoid arthritis	9.42e-05	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—UBE2D1—rheumatoid arthritis	9.39e-05	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.38e-05	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL5—rheumatoid arthritis	9.24e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL12—rheumatoid arthritis	9.21e-05	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BDKRB2—rheumatoid arthritis	9.21e-05	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—POMC—rheumatoid arthritis	9.2e-05	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VEGFA—rheumatoid arthritis	9.14e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP3—rheumatoid arthritis	9.14e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—TYK2—rheumatoid arthritis	9.14e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	9.13e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	9.11e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—rheumatoid arthritis	9.11e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CSF2—rheumatoid arthritis	9.1e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MTHFR—rheumatoid arthritis	9.08e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2—rheumatoid arthritis	8.96e-05	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAT—rheumatoid arthritis	8.84e-05	0.000118	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—POMC—rheumatoid arthritis	8.83e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTK2—rheumatoid arthritis	8.8e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	8.76e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL5—rheumatoid arthritis	8.63e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	8.59e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SYK—rheumatoid arthritis	8.56e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SPP1—rheumatoid arthritis	8.55e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.52e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—rheumatoid arthritis	8.51e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CSF2—rheumatoid arthritis	8.5e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	8.41e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—rheumatoid arthritis	8.39e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2—rheumatoid arthritis	8.37e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—rheumatoid arthritis	8.35e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR5—rheumatoid arthritis	8.32e-05	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT1—rheumatoid arthritis	8.26e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2RA—rheumatoid arthritis	8.2e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL2—rheumatoid arthritis	8.17e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6R—rheumatoid arthritis	8.15e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL10—rheumatoid arthritis	8.14e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2—rheumatoid arthritis	8.14e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—C3—rheumatoid arthritis	8.13e-05	0.000109	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—rheumatoid arthritis	8.05e-05	0.000108	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	8e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SPP1—rheumatoid arthritis	7.99e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.95e-05	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR5—rheumatoid arthritis	7.77e-05	0.000104	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—rheumatoid arthritis	7.7e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2RA—rheumatoid arthritis	7.66e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2—rheumatoid arthritis	7.6e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—C3—rheumatoid arthritis	7.6e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LEP—rheumatoid arthritis	7.57e-05	0.000101	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP3—rheumatoid arthritis	7.42e-05	9.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	7.42e-05	9.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—rheumatoid arthritis	7.38e-05	9.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—rheumatoid arthritis	7.26e-05	9.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	7.15e-05	9.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FN1—rheumatoid arthritis	7.14e-05	9.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	7.11e-05	9.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6ST—rheumatoid arthritis	7.11e-05	9.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LEP—rheumatoid arthritis	7.07e-05	9.46e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—rheumatoid arthritis	7.04e-05	9.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	7.01e-05	9.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	6.91e-05	9.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	6.9e-05	9.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD80—rheumatoid arthritis	6.84e-05	9.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	6.8e-05	9.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FN1—rheumatoid arthritis	6.67e-05	8.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6ST—rheumatoid arthritis	6.64e-05	8.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—rheumatoid arthritis	6.62e-05	8.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	6.5e-05	8.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	6.49e-05	8.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.46e-05	8.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD80—rheumatoid arthritis	6.39e-05	8.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	6.36e-05	8.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	6.34e-05	8.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—rheumatoid arthritis	6.34e-05	8.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	6.31e-05	8.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	6.22e-05	8.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	6.17e-05	8.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	6.17e-05	8.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—rheumatoid arthritis	6.07e-05	8.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL2—rheumatoid arthritis	5.94e-05	7.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6R—rheumatoid arthritis	5.93e-05	7.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—rheumatoid arthritis	5.9e-05	7.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—rheumatoid arthritis	5.79e-05	7.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	5.78e-05	7.73e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAT—rheumatoid arthritis	5.76e-05	7.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	5.74e-05	7.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	5.67e-05	7.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	5.42e-05	7.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	5.4e-05	7.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	5.39e-05	7.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—rheumatoid arthritis	5.38e-05	7.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	5.3e-05	7.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	5.19e-05	6.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	5.15e-05	6.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	5.03e-05	6.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	4.93e-05	6.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	4.83e-05	6.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	4.81e-05	6.44e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	4.81e-05	6.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	4.81e-05	6.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	4.78e-05	6.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	4.71e-05	6.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	4.7e-05	6.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	4.55e-05	6.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.5e-05	6.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	4.49e-05	6.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	4.47e-05	5.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.43e-05	5.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	4.38e-05	5.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	4.3e-05	5.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	4.25e-05	5.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	4.2e-05	5.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	4.13e-05	5.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	4.09e-05	5.47e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—rheumatoid arthritis	3.84e-05	5.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.82e-05	5.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	3.82e-05	5.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.75e-05	5.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	3.65e-05	4.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	3.63e-05	4.86e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—rheumatoid arthritis	3.51e-05	4.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	3.5e-05	4.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	3.45e-05	4.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.42e-05	4.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.36e-05	4.49e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	3.35e-05	4.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.1e-05	4.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	3.09e-05	4.13e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	3.07e-05	4.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	2.88e-05	3.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.85e-05	3.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	2.83e-05	3.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	2.64e-05	3.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	2.34e-05	3.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	2.14e-05	2.87e-05	CbGpPWpGaD
